Login

Journal Front Page

News & Events

  • Call for article for January 2027 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2026 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2026 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 15, Issue 4 (October 2026 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

DEVELOPMENT AND EVALUATION OF ANTI-OBESITY POLYHERBAL FORMULATION CONTAINING BRYONIA LACINIOSA AND FICUS RACEMOSA: A COMPREHENSIVE IN VITRO AND IN VIVO INVESTIGATION

Babli Patel*, Harshita Jain, Vaishali Yadav, Arpit Shrivastav

Adina institute of Pharmaceutical Sciences, Sagar (M.P.), India

ABSTRACT

Obesity represents a global pandemic requiring safe and effective therapeutic interventions. Traditional medicinal plants offer promising alternatives to synthetic anti-obesity drugs with potentially fewer adverse effects. This study investigated the anti-obesity potential of a novel polyherbal formulation combining Bryonia laciniosa and Ficus racemosa extracts. Ethanolic extracts of B. laciniosa seeds and F. racemosa bark were prepared and characterized through phytochemical screening. In vitro antioxidant activity was assessed using DPPH and FRAP assays, while pancreatic lipase inhibition was evaluated spectrophotometrically. Acute toxicity studies followed OECD guidelines. Anti-dyslipidemic effects were evaluated in Triton X-100-induced hyperlipidemic rats. A polyherbal tablet formulation was developed and optimized, followed by anti-obesity evaluation in high-fat diet-induced obese rats. Both extracts demonstrated significant antioxidant activity (IC₅₀: B. laciniosa 96.85 ± 0.04 μg/mL; F. racemosa 115.82 ± 0.06 μg/mL) and pancreatic lipase inhibition (IC₅₀: 27.70 ± 0.15 and 36.88 ± 0.14 μg/mL, respectively). In hyperlipidemic rats, treatment significantly reduced total cholesterol, triglycerides, LDL, and VLDL while increasing HDL levels (p < 0.01). The optimized polyherbal tablet (PHT4) demonstrated superior anti-obesity effects in high-fat diet-induced obese rats, significantly reducing body weight, serum lipids, and hepatic lipid accumulation compared to disease controls (p < 0.01). The polyherbal formulation combining B. laciniosa and F. racemosa extracts exhibits significant anti-obesity and anti-dyslipidemic properties through multiple mechanisms including pancreatic lipase inhibition and antioxidant activity. These findings support the potential clinical application of this formulation for obesity management.

Keywords: Anti-obesity, Bryonia laciniosa, Ficus racemosa, polyherbal formulation, pancreatic lipase inhibition, dyslipidemia.


[Full Text Article]